Tag: tangeretin

Articles

• Supplements with warnings for breast cancer

Foods

• • oranges

Studies

• Molecular mechanisms of flavonoids and their modulatory effects against breast cancer: A scoping review Cite
  Murithi M, Wambugu E, Nyanjom S, Mobegi V, Shahin S, Makokha F. Molecular mechanisms of flavonoids and their modulatory effects against breast cancer: A scoping review. F1000Research. F1000 Research Ltd; 2022; 11:293 10.12688/f1000research.108908.1
• Cholesterol Depletion Modulates Drug Resistance Pathways to Sensitize Resistant Breast Cancer Cells to Tamoxifen Cite
  HENRIQUES PALMA GB, KAUR M. Cholesterol Depletion Modulates Drug Resistance Pathways to Sensitize Resistant Breast Cancer Cells to Tamoxifen. Anticancer Research. Anticancer Research USA Inc.; 2021; 42:565-579 10.21873/anticanres.15514
• Role of Flavonoids as Epigenetic Modulators in Cancer Prevention and Therapy Cite
  Fatima N, Baqri SSR, Bhattacharya A, Koney NK, Husain K, Abbas A, et al. Role of Flavonoids as Epigenetic Modulators in Cancer Prevention and Therapy. Frontiers in Genetics. Frontiers Media SA; 2021; 12 10.3389/fgene.2021.758733
• Incipient citrus polymethoxylated flavone Tangeretin as anticancer drug candidate: Mechanistic insights, limitations and possible solutions Cite
  Boye A, Ahmad I, Fakhri S, Hussain Y, Khan H. Incipient citrus polymethoxylated flavone Tangeretin as anticancer drug candidate: Mechanistic insights, limitations and possible solutions. Advances in Cancer Biology - Metastasis. Elsevier BV; 2021; 3:100010 10.1016/j.adcanc.2021.100010
• Tangeretin boosts the anticancer activity of metformin in breast cancer cells via curbing the energy production Cite
  Mdkhana B, Zaher DM, Abdin SM, Omar HA. Tangeretin boosts the anticancer activity of metformin in breast cancer cells via curbing the energy production. Phytomedicine. Elsevier BV; 2021;:153470 10.1016/j.phymed.2021.153470
• Inhibitory Effects of Tangeretin, a Citrus Peel-Derived Flavonoid, on Breast Cancer Stem Cell Formation through Suppression of Stat3 Signaling Cite
  Ko Y, Choi HS, Liu R, Kim J, Kim S, Yun B, et al. Inhibitory Effects of Tangeretin, a Citrus Peel-Derived Flavonoid, on Breast Cancer Stem Cell Formation through Suppression of Stat3 Signaling. Molecules. MDPI AG; 2020; 25:2599 10.3390/molecules25112599
• The Combined Effect of Pomegranate Extract and Tangeretin on the DMBA-induced Breast Cancer Model Cite
  Gul HF, Ilhan N, Ilhan N, Ozercan IH, Kuloglu T. The Combined Effect of Pomegranate Extract and Tangeretin on the DMBA-induced Breast Cancer Model. The Journal of Nutritional Biochemistry. Elsevier BV; 2020;:108566 10.1016/j.jnutbio.2020.108566
• Predicting and Quantifying Antagonistic Effects of Natural Compounds Given with Chemotherapeutic Agents: Applications for High-Throughput Screening Cite
  Hackman GL, Collins M, Lu X, Lodi A, DiGiovanni J, Tiziani S. Predicting and Quantifying Antagonistic Effects of Natural Compounds Given with Chemotherapeutic Agents: Applications for High-Throughput Screening. Cancers. MDPI AG; 2020; 12:3714 10.3390/cancers12123714
• Bioinformatic analysis reveals the molecular targets of tangeretin in overcoming the resistance of breast cancer to tamoxifen Cite
  Hermawan A, Putri H, Ikawati M. Bioinformatic analysis reveals the molecular targets of tangeretin in overcoming the resistance of breast cancer to tamoxifen. Gene Reports. Elsevier BV; 2020; 21:100884 10.1016/j.genrep.2020.100884
• Association between flavonoids, flavonoid subclasses intake and breast cancer risk: a case-control study in China Cite
  Feng X, Ho SC, Mo X, Lin F, Zhang N, Luo H, et al. Association between flavonoids, flavonoid subclasses intake and breast cancer risk: a case-control study in China. European Journal of Cancer Prevention. Ovid Technologies (Wolters Kluwer Health); 2019; 29:493-500 10.1097/cej.0000000000000561
• Tangeretin inhibits the proliferation of human breast cancer cells via CYP1A1/CYP1B1 enzyme induction and CYP1A1/CYP1B1–mediated metabolism to the product 4′ hydroxy tangeretin Cite
  Surichan S, Arroo RR, Tsatsakis AM, Androutsopoulos VP. Tangeretin inhibits the proliferation of human breast cancer cells via CYP1A1/CYP1B1 enzyme induction and CYP1A1/CYP1B1–mediated metabolism to the product 4′ hydroxy tangeretin. Toxicology in Vitro. Elsevier BV; 2018; 50:274-284 10.1016/j.tiv.2018.04.001
• Role of tangeretin as a potential bioavailability enhancer for silybin: Pharmacokinetic and pharmacological studies Cite
  Yuan Z, Li Y, Liu Z, Feng S, Zhou H, Liu C, et al. Role of tangeretin as a potential bioavailability enhancer for silybin: Pharmacokinetic and pharmacological studies. Pharmacological Research. Elsevier BV; 2018; 128:153-166 10.1016/j.phrs.2017.09.019
• Tangeretin attenuates cisplatin-induced renal injury in rats: Impact on the inflammatory cascade and oxidative perturbations Cite
  Arab HH, Mohamed WR, Barakat BM, Arafa EA. Tangeretin attenuates cisplatin-induced renal injury in rats: Impact on the inflammatory cascade and oxidative perturbations. Chemico-Biological Interactions. Elsevier BV; 2016; 258:205-213 10.1016/j.cbi.2016.09.008
• Enhanced Anti-Inflammatory Activities by the Combination of Luteolin and Tangeretin Cite
  Funaro A, Wu X, Song M, Zheng J, Guo S, Rakariyatham K, et al. Enhanced Anti-Inflammatory Activities by the Combination of Luteolin and Tangeretin. Journal of Food Science. Wiley; 2016; 81:H1320-H1327 10.1111/1750-3841.13300
• Tangeretin, a citrus pentamethoxyflavone, antagonizes ABCB1-mediated multidrug resistance by inhibiting its transport function Cite
  Feng S, Yuan Z, Yao X, Ma W, Liu L, Liu Z, et al. Tangeretin, a citrus pentamethoxyflavone, antagonizes ABCB1-mediated multidrug resistance by inhibiting its transport function. Pharmacological Research. Elsevier BV; 2016; 110:193-204 10.1016/j.phrs.2016.04.003
• Tangeretin Alleviates Cisplatin-Induced Acute Hepatic Injury in Rats: Targeting MAPKs and Apoptosis Cite
  Omar HA, Mohamed WR, Arab HH, Arafa EA. Tangeretin Alleviates Cisplatin-Induced Acute Hepatic Injury in Rats: Targeting MAPKs and Apoptosis. PLOS ONE. Public Library of Science (PLoS); 2016; 11:e0151649 10.1371/journal.pone.0151649
• Influence of Tangeretin on Tamoxifen's Therapeutic Benefit in Mammary Cancer Cite
  Bracke ME, Depypere HT, Boterberg T, Van Marck VL, Vennekens KM, Vanluchene E, et al. Influence of Tangeretin on Tamoxifen's Therapeutic Benefit in Mammary Cancer. JNCI Journal of the National Cancer Institute. Oxford University Press (OUP); 1998; 91:354-359 10.1093/jnci/91.4.354
• Flavonoids and Breast Cancer Risk in Italy Cite
  Bosetti C. Flavonoids and Breast Cancer Risk in Italy. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2005; 14:805-808 10.1158/1055-9965.epi-04-0838